The sources your Daily Try draws from

Dementia develops in someone somewhere in the world every three seconds.

Memory loss is treated as the end point of many contributing pressures rather than one disease with one cause.

Seven contributor groups frame cognitive decline: lifestyle habits, environmental toxins, infections, hormones, detoxification, chronic inflammation and precision or functional medicine.

Hormonal or thyroid problems can mimic or accelerate cognitive decline, according to several speakers.

Maskell warns that a Teflon non-stick pan can shed microplastics, so millions of particles may cancel the benefit of cooking organic food.

Burke says reversing Alzheimer's requires identifying every contributing cause in a person and starting correction without delay.

Burke splits reversal into brain pillars the patient does personally and root causes the clinician must find and address.

Burke finds patients who failed with other practitioners were usually missing one unaddressed cause, not receiving wrong care.

Burke compares brain recovery to a jigsaw puzzle that cannot be finished while one piece is still missing.

Burke says time is brain loss, so cognitive decline needs many causes addressed rapidly at once, unlike slower chronic illnesses.

A three-year randomized controlled trial at six sites tested precision medicine against standard care for early Alzheimer's and cognitive decline.

Burke reports a 92% overall improvement rate in the trial's precision-medicine group, with p values below 0.001.

Control patients in the precision-medicine trial showed minimal symptom improvement and actual declines in memory and cognitive performance.

A randomized trial's control group shows improvement came from the intervention, which earlier uncontrolled pilot data could not prove.

Almost all doctors in the precision-medicine trial were family physicians, suggesting primary care can catch and reverse early decline.

Family physicians see patients for years before diagnosis, so they can notice small cognitive changes while more brain can be saved.

Burke says the main barrier to spreading precision care is the enormous volume of patient data each clinician must synthesize.

Network insufficiency is the idea that Alzheimer's arises when many biological networks fail together rather than one faulty mechanism.

Maskell argues 14 drug mechanisms under study at once implies Alzheimer's is multifactorial, since a single cause would have shown progress.

Burke hopes root-cause correction could later make anti-amyloid drugs profoundly more effective, by putting out the fire first.

Burke says genetics may prime type 2 diabetes, but choices and exposures express it, so she reverses it most of the time.

Type 2 diabetes, vascular disease and Alzheimer's share metabolic dysfunction, vessel-wall injury and leaky blood vessels as root mechanisms.

Burke calls mold a heavy anchor that holds down progress and drags back improvement a patient has already achieved.

Richard Horowitz reported a case where his Lyme therapy improved cognition and reversed an elevated Alzheimer's blood marker.

Burke says toxin identification alone heals nothing and removal without identification is guesswork, so both must go together.

Removing toxins halts the chronic inflammation and oxidative stress that damage cells, tissues and organs, according to Burke.

A gut-permeability protein and LPS open the gut barrier, and gut barrier failure is carried to the blood-brain barrier.

Burke repairs the blood-brain barrier by removing toxins, controlling gut leakage of LPS and rebuilding the endothelium and glycocalyx.

Burke compares barrier damage to a leak and a puddle, where neurodegeneration is the puddle proving barriers already failed.

Maskell says a team of doctors, physician assistants, nutritionists and health coaches seemed the only system consistently reversing decline.